DMD #37358

ABSTRACT:
Isoflurane is an inhaled halogenated hydrocarbon anesthetic commonly used for animal research. In our quest to develop a method for measuring bile acid transport in live animals using 19 F magnetic resonance (MR) imaging, it occurred to us that isoflurane, which contain five fluorines per molecule and is likely widely distributed, would provide an excellent test drug to evaluate the merits of this approach.
Experiments in 20-28 g male C57BL/6 mice were performed using a Bruker Biospec 7.0 
DMD #37358 Introduction
In the course of studying bile acid transport using an in vitro assay system, we observed that many commonly-used drugs inhibit the function of the major intestinal bile acid transporter, the apical sodium-dependent bile acid transporter (ASBT; gene name SLC10A2) (Zheng et al., 2009) . These ASBT inhibitors include 3-hydroxy-3-methylglutaryl-coenzyme A inhibitors (statins) and dihydropyridine calcium-channel blockers; statins and calcium-channel blockers are amongst the most commonly prescribed drugs in the United States. Inhibition of ASBT results in reduced intestinal uptake of bile acids and increased fecal bile acid concentrations, a risk factor for colon pathology, including cancer (Flynn et al., 2007) . Hence, side-effects deriving from drug-induced inhibition of ASBT could pose potential, currently unappreciated risk.
Based on these observations we decided to develop a new in vivo assay to measure the ability of drugs to inhibit bile acid transport. Currently available methods to measure bile acid transport in vivo are limited to 75 Se-25-homocholic acid-taurine ( 75 SeHCAT) (Boyd et al., 1981; Fracchia et al., 1998) and luciferase-FXR imaging (Houten et al., 2007) . 75 SeHCAT, which was not approved by the U.S. Food and Drug Administration and available only in Europe, requires administration of a radioactive agent (Pattni et al., 2009 ) and its production was recently discontinued by the supplier (European Amersham catalogs). Luciferase-FXR imaging is applicable only in transgenic mice expressing the reporter gene and provides very limited anatomical detail (Houten et al., 2007 (Jiang et al., 2009 F signal of sufficient strength for detection. Because rats lack a gallbladder, mice would serve this purpose, and were previously used as test animals for studies of bile acid transport (Dawson et al., 2003) ,. Second, a fluoridated test agent was required to validate the approach. Fluoridated hydrocarbons, particularly 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane (isoflurane) (Fig. 1) , are commonly used to anesthetize mice, and wide tissue distribution as well as limited hepatic metabolism of this agent, is reported (Kharasch et al., 1993; Wissing et al., 2000; Kharasch, 2008) [Forane (Isoflurane) package insert]. Hence, isoflurane which contains five fluorines per molecule ( Fig. 1) appeared to be an ideal test agent. Moreover, among the volatile halogenated anesthetics, isoflurane appears to undergo the least amount of defluorination (Kharasch et al., 1993) . Almost 30 years ago, it was shown that high-resolution 19 F magnetic resonance spectra from isoflurane could be obtained from a surface coil centered over the brain of a living rabbit (Wyrwicz et al., 1983) .
Therefore, in the present study, we investigated whether isoflurane could be measured in mouse gallbladder bile using in vivo MRI. To verify the presence of isoflurane in gallbladder bile and estimate the limits of detection, we used liquid chromatography-mass spectrometry (LC-MS). The data presented here provide proofof-concept that this novel approach can be used for in vivo measurement of biliary excretion of both existing and novel Laboratories, North Chicago, IL). Animals were then placed supine in a Bruker animal bed and the RF coil was positioned and fixed with surgical tape in the region of interest on the animal body. The animal bed was moved to the center of the magnet and the isoflurane level was changed to 1.5% and maintained at this level for the remainder of the experiment. An MR-compatible small-animal monitoring and gating system (SA Instruments, Inc., New York, NY) was used to monitor animal respiration rate and body temperature. Mouse body temperature was maintained at 36-37 o C using a warm water circulator.
Localization of the gallbladder was attained by first obtaining images using 1 H-MRI.
Three-slice (axial, mid-sagittal, and coronal) scout rapid acquisition with fast low angle shot MR imaging (FLASH) was used to first localize the volume of interest. High resolution proton density-weighted anatomic images were acquired using rapid 
Liquid chromatography-mass spectrometry (LC-MS).
In parallel studies, to measure isoflurane content in gallbladder bile, mice were dosed with isoflurane using the same protocol described for live animal MRI. Mice were euthanized immediately after completing isoflurane inhalation and the gallbladders removed and weighed. Tissue samples were transported in tightly sealed containers with minimal head-space and stored on ice prior to sample preparation. The gallbladder was ground using a tissue homogenizer in the presence of 75:25::acetonitrile:water solvent. Homogenized tissue was centrifuged (9600 g for 1 min; 4°C) and isoflurane content of the supernatant was measured using LC-MS. LC-MS was conducted using a TSQ Vantage (Thermo Scientific) mass spectrometer, with Accela 1250 pump and PAL HTC-Accela1-TM autosampler. The column was a Phenomenex Gemni C18 (50 X 4.6 mm, 3 u, 110 A).
The mobile phase (1.2 mL/min, water and acetonitrile) was a gradient of: 0 -0.5 min, 40% ACN; 0.5 -1.5 min, 40% to 95% ACN; 1.5 -2.5 min, 95% ACN; 2.5 -2.6 min, 95% to 40% ACN; and 2.6 -3.6 min, 40% ACN. MS was performed using an APCI probe, in negative mode; ion transition m/z 183 
Results and Discussion
Exhalation is the major route of elimination for halogenated hydrocarbon anesthetics like isoflurane (Fig. 1) . Based on both in vitro and in vivo data, it is estimated that liver metabolism, primarily by CYP2E1, contributes only 0.1 -2% of isoflurane elimination (Kharasch, 2008; Kharasch et al., 1993) . The major metabolite resulting from CYP2E1 metabolism of isoflurane is trifluoroacetyl chloride (Kharasch, 2008; Kharasch et al., 1993; Njoku et al., 1997) . Minimal metabolism by the liver is thought to be the major reason that isoflurane poses a lower risk of hepatotoxicity than other halogenated anesthetics, like halothane (Christ et al., 1988; Kharasch, 2008; Njoku et al., 1997) .
Although isoflurane is widely distributed (Wissing et al., 2000) , no report has investigated its distribution into bile. Nevertheless, we focused our studies on imaging isoflurane in the gallbladder; exobiotics can be excreted by the liver into the biliary tree and both stored and concentrated in the gallbladder. Consequently, we reasoned that we were most likely to detect the strongest 19 F signal in gallbladder bile. The mouse gallbladder is well revealed by proton MRI in the anterior upper abdomen (Fig. 2A) . The identity of the gallbladder on MR imaging was confirmed by immediate post-imaging animal dissection (Fig. 2B ).
Our initial experiments used the same scan resolution for proton and fluorine imaging. However, due to the relative weaker sensitivity of fluorine, in subsequent studies we modified MR imaging to obtain 4-mm slice thickness for performed in five mice. Four mice were treated with inhaled isoflurane as described in Methods and one control mouse received subcutaneous non-halogenated anesthetics (no isoflurane). As an unplanned control, the gallbladder of one of the four isofluranetreated mice was emptied of bile prior to removal, such that no isoflurane was detected in that mouse. Table 1 lists the amount of isoflurane in each mouse gallbladder. No isoflurane was found in gallbladders from the two control mice; one that did not receive isoflurane and one whose gallbladder emptied before assay. In the remaining three isoflurane-treated mice, 4.72, 3.25 and 3.52 μ g isoflurane was detected in the gallbladder (mean ± SE, 3.83 ± 0.45 μ g) (Table 1) . Although the volume of gallbladder contents was not measured, we estimated isoflurane concentration in gallbladder bile based on published data relating gallbladder volume to mouse weight (Graewin et al., 2004) . This analysis yielded gallbladder bile isoflurane concentrations of 2.2, 1.3 and 1.4 mM, respectively (Table 1 ). This suggests that the limits of detection for isoflurane using 19 F MRI are at least 1 to 2 mM.
Regarding the use of this approach for measuring bile acid transport, an advantage of MR imaging of the gallbladder is that bile acids are stored in this organ. It is estimated that after an overnight fast, at least 80% of the bile acid pool is stored in the gallbladder (Nilsell, 1990) . The amount of 19 F-labeled bile acid tracer that accumulates in the mouse gallbladder during an overnight fast will depend on the test dose, stability, absorption, mouse body weight and other factors. Nonetheless, using conservative estimates, we calculate that gavaging mice with Isoflurane content of mouse gallbladder bile was measured using LC-MS; TSQ Vantage mass spectrometer, with Accela 1250 pump and PAL HTC-Accela1-TM autosampler. The column was a Phenomenex Gemni C18 (50 X 4.6 mm, 3 u, 110 A).
The mobile phase (1.2 mL/min, water and acetonitrile) was a gradient of: 0 -0.5 min, 40% ACN; 0.5 -1.5 min, 40% to 95% ACN; 1.5 -2.5 min, 95% ACN; 2.5 -2.6 min, 95% to 40% ACN; and 2.6 -3.6 min, 40% ACN. MS was performed using an APCI (Graewin et al., 2004) .
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